The present invention relates to Pharmaceutical composition and use joint product to treat the method for thrombotic disease described joint product contains [4-(6-fluoro-7-methylamino-2 4-dioxo-1,4-dihydro-2H-quinazoline-3-yl)-phenyl]-5-chloro-thiophene-2-base-sulfonylurea or its officinal salt.